274 related articles for article (PubMed ID: 25098305)
21. Upper respiratory tract disease and mycoplasmosis in desert tortoises from Nevada.
Lederle PE; Rautenstrauch KR; Rakestraw DL; Zander KK; Boone JL
J Wildl Dis; 1997 Oct; 33(4):759-65. PubMed ID: 9391959
[TBL] [Abstract][Full Text] [Related]
22. Western blot can distinguish natural and acquired antibodies to Mycoplasma agassizii in the desert tortoise (Gopherus agassizii).
Hunter KW; Dupré SA; Sharp T; Sandmeier FC; Tracy CR
J Microbiol Methods; 2008 Dec; 75(3):464-71. PubMed ID: 18708096
[TBL] [Abstract][Full Text] [Related]
23. Investigation of a Large-Scale Gopher Tortoise ( Gopherus polyphemus) Mortality Event on a Public Conservation Land in Florida, USA.
Dziadzio MC; Sievers ER; Burr D
J Wildl Dis; 2018 Oct; 54(4):809-813. PubMed ID: 29792758
[TBL] [Abstract][Full Text] [Related]
24. Quantitative PCR method for detection of mycoplasma spp. DNA in nasal lavage samples from the desert tortoise (Gopherus agassizii).
duPre' SA; Tracy CR; Hunter KW
J Microbiol Methods; 2011 Aug; 86(2):160-5. PubMed ID: 21565225
[TBL] [Abstract][Full Text] [Related]
25. Bilateral palpebral reduction and concurrent mycoplasmosis in a wild Agassiz's desert tortoise (Gopherus agassizii).
Jacobson ER; Berry KH; Brooks DE; Roberts JF
Vet Ophthalmol; 2023 Jul; 26(4):361-366. PubMed ID: 37030880
[TBL] [Abstract][Full Text] [Related]
26. Mycoplasma agassizii sp. nov., isolated from the upper respiratory tract of the desert tortoise (Gopherus agassizii) and the gopher tortoise (Gopherus polyphemus).
Brown MB; Brown DR; Klein PA; McLaughlin GS; Schumacher IM; Jacobson ER; Adams HP; Tully JG
Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):413-418. PubMed ID: 11321087
[TBL] [Abstract][Full Text] [Related]
27. High quality draft genome sequences of
Alvarez-Ponce D; Weitzman CL; Tillett RL; Sandmeier FC; Tracy CR
Stand Genomic Sci; 2018; 13():12. PubMed ID: 29725499
[No Abstract] [Full Text] [Related]
28. Improved enzyme-linked immunosorbent assay to reveal Mycoplasma agassizii exposure: a valuable tool in the management of environmentally sensitive tortoise populations.
Wendland LD; Zacher LA; Klein PA; Brown DR; Demcovitz D; Littell R; Brown MB
Clin Vaccine Immunol; 2007 Sep; 14(9):1190-5. PubMed ID: 17626160
[TBL] [Abstract][Full Text] [Related]
29. Identifying genome-wide immune gene variation underlying infectious disease in wildlife populations - a next generation sequencing approach in the gopher tortoise.
Elbers JP; Brown MB; Taylor SS
BMC Genomics; 2018 Jan; 19(1):64. PubMed ID: 29351737
[TBL] [Abstract][Full Text] [Related]
30. Impacts of upper respiratory tract disease on olfactory behavior of the Mojave desert tortoise.
Germano J; Van Zerr VE; Esque TC; Nussear KE; Lamberski N
J Wildl Dis; 2014 Apr; 50(2):354-8. PubMed ID: 24506425
[TBL] [Abstract][Full Text] [Related]
31. A novel mycoplasma detected in association with upper respiratory disease syndrome in free-ranging eastern box turtles (Terrapene carolina carolina) in Virginia.
Feldman SH; Wimsatt J; Marchang RE; Johnson AJ; Brown W; Mitchell JC; Sleeman JM
J Wildl Dis; 2006 Apr; 42(2):279-89. PubMed ID: 16870850
[TBL] [Abstract][Full Text] [Related]
32. Island of misfit tortoises: waif gopher tortoise health assessment following translocation.
McKee RK; Buhlmann KA; Moore CT; Allender MC; Stacy NI; Tuberville TD
Conserv Physiol; 2022; 10(1):coac051. PubMed ID: 37501911
[TBL] [Abstract][Full Text] [Related]
33. Mycoplasma agassizii strain variation and distinct host antibody responses explain differences between enzyme-linked immunosorbent assays and Western blot assays.
Wendland LD; Klein PA; Jacobson ER; Brown MB
Clin Vaccine Immunol; 2010 Nov; 17(11):1739-45. PubMed ID: 20810678
[TBL] [Abstract][Full Text] [Related]
34. Mycoplasma agassizii causes upper respiratory tract disease in the desert tortoise.
Brown MB; Schumacher IM; Klein PA; Harris K; Correll T; Jacobson ER
Infect Immun; 1994 Oct; 62(10):4580-6. PubMed ID: 7927724
[TBL] [Abstract][Full Text] [Related]
35. Mycoplasma testudineum sp. nov., from a desert tortoise (Gopherus agassizii) with upper respiratory tract disease.
Brown DR; Merritt JL; Jacobson ER; Klein PA; Tully JG; Brown MB
Int J Syst Evol Microbiol; 2004 Sep; 54(Pt 5):1527-1529. PubMed ID: 15388705
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive health assessment and blood analyte reference intervals of gopher tortoises (
Page-Karjian A; Rafferty K; Xavier C; Stacy NI; Moore JA; Hirsch SE; Clark S; Manire CA; Perrault JR
Conserv Physiol; 2021; 9(1):coab015. PubMed ID: 33815802
[TBL] [Abstract][Full Text] [Related]
37. Persistence of maternal antibodies against Mycoplasma agassizii in desert tortoise hatchlings.
Schumacher IM; Rostal DC; Yates RA; Brown DR; Jacobson ER; Klein PA
Am J Vet Res; 1999 Jul; 60(7):826-31. PubMed ID: 10407474
[TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of Pasteurella testudinis isolated from desert tortoises (Gopherus agassizii) with and without upper respiratory tract disease.
Snipes KP; Kasten RW; Calagoan JM; Boothby JT
J Wildl Dis; 1995 Jan; 31(1):22-9. PubMed ID: 7563420
[TBL] [Abstract][Full Text] [Related]
39. Detection of antibodies to a pathogenic mycoplasma in desert tortoises (Gopherus agassizii) with upper respiratory tract disease.
Schumacher IM; Brown MB; Jacobson ER; Collins BR; Klein PA
J Clin Microbiol; 1993 Jun; 31(6):1454-60. PubMed ID: 8314986
[TBL] [Abstract][Full Text] [Related]
40. Mycoplasmal upper respiratory tract disease across the range of the threatened Mojave Desert tortoise: associations with thermal regime and natural antibodies.
Sandmeier FC; Tracy CR; Hagerty BE; DuPré S; Mohammadpour H; Hunter K
Ecohealth; 2013 Mar; 10(1):63-71. PubMed ID: 23579813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
